# ArchiMed acquires majority stake in NAMSA

Private equity firm ArchiMed acquired a majority stake in NAMSA, a medical device testing CRO, from the Gorski Family. The price was undisclosed.

- Type: Acquisition
- Announced: 2020-09-01
- Where: Toledo, Ohio, United States
- Status: completed
- Products: medical device testing services
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ARCHIMED](https://endata.com/companies/34181.md) (acquirer)
- [NAMSA](https://endata.com/companies/49644.md) (target)

## Sources

- [biospace.com](https://www.biospace.com/partnering-with-existing-owners-and-management-archimed-acquires-majority-interest-in-namsa-the-world-leader-in-medical-device-testing), 2020-09-01: "Investment from a strategic partner is essential for NAMSA’s next era of growth."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.